Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

Detalles Bibliográficos
Autores principales: Taylor, Matthew, Antonia, Scott, Bendell, Johanna, Calvo, Emiliano, Jäger, Dirk, de Braud, Filippo, Ott, Patrick A, Pietanza, M Catherine, Horn, Leora, Le, Dung T, Morse, Michael A, López-Martin, José A, Ascierto, Paolo A, Christensen, Olaf, Simon, Jason S, Lin, Chen-Sheng, Eder, Joseph Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649441/
http://dx.doi.org/10.1186/2051-1426-3-S2-P376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649441/
http://dx.doi.org/10.1186/2051-1426-3-S2-P376

Ejemplares similares